Skip to content
Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

Primary Menu Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

  • Home
  • Newswires
  • Politics & Society
  • The New Feudals
  • World View
  • Arts And Aesthetics
  • For The Record
  • About Us
  • Featured

India Set To Ship Coronavirus Drug Sought By Trump

Apr 11, 2020 | Pratirodh Bureau

Laura Ng, who has lupus and had to recently call at least five pharmacies before she could find a place to fill her hydroxychloroquine prescription, is photographed in Seattle, Washington, U.S. on March 31, 2020

India is set to begin shipping the malaria drug hydroxychloroquine to the United States where President Donald Trump has touted it as a potential weapon against the coronavirus.

“The first shipments should start next week,” said Sudarshan Jain, secretary general of Indian Pharmaceutical Alliance (IPA).

India is the world’s largest producer of hydroxychloroquine but last month banned most exports to secure its own supplies, drawing warnings of retaliation from Trump.

This week India allowed some exports of the drug and Trump has thanked New Delhi for the decision.

Jain said companies in India are ramping up capacity to meet the U.S. demand, including Teva Pharmaceutical Industries, IPCA Laboratories and Cadila Healthcare.

Cadila has increased production tenfold to 30 metric tonnes per month and is ready to produce more if needed, Managing Director Sharvil Patel told Reuters.

Companies are ramping up while battling a three-week nationwide lockdown imposed on March 25.

Cadila is based in Gujarat, a drug production hub where industry insiders say the shutdown has forced companies to contend with supply chain disruptions and worker shortages.

“There are 28 manufacturers of hydroxychloroquine in Gujarat,” said H.G. Koshia, a senior drugs department official. “All of them have enhanced production in view of rise in demand.”

The IPA’s Jain said firms were confident they could produce adequate quantities to meet both global and domestic demand.

“The government is getting a lot of requests from other countries,” Jain noted.

India is stocking at least four months’ supply and has agreed to export to at least 30 countries, according to export body Pharmexcil’s estimates.

Hydroxychloroquine is unproven as a treatment but its use has soared as the United States has quickly become the epicentre of the pandemic.

U.S. deaths due to coronavirus topped 16,400, while India’s death toll stands at 199.

Tags: Cadila Healthcare, coronavirus, hydroxychloroquine, Indian Pharmaceutical Alliance, IPA, IPCA Laboratories, Pharmexcil, Pratirodh, Teva Pharmaceutical Industries, U.S. President Donald Trump

Continue Reading

Previous Covid-19 Relief Plan Could Leave Millions Sans Food Aid
Next India Ramps Up Covid-19 Tests As Cases Top 6,700

More Stories

  • Featured

Iran May Now Turn To Asymmetrical Warfare – Raising Risk Of Proxy Attacks

3 hours ago Pratirodh Bureau
  • Featured

Book Review: A Fascinating Book On India’s Rivers And Their Travails

9 hours ago Shalini
  • Featured

Giving Floral Waste A Second Life

11 hours ago Pratirodh Bureau

Recent Posts

  • Iran May Now Turn To Asymmetrical Warfare – Raising Risk Of Proxy Attacks
  • Book Review: A Fascinating Book On India’s Rivers And Their Travails
  • Giving Floral Waste A Second Life
  • US Bombs Iran’s Nuclear Sites: What Led To It, What Happens Next?
  • Negotiating Realities In Frosty India-Bangladesh Relations
  • Of India’s Digital Divide And The Consequent Welfare Bias
  • Running On Sunshine, Running Out Of Water
  • M.B. Chitampalli, Forests’ Living Encyclopedia, Dies At 93
  • Green Tribunal Issues Order States/UTs To Stop Concretising Tree Bases
  • Why India’s Poverty Decline May Not Be What It Appears To Be
  • Trump–Munir Lunch Is A Huge Blow To Indian Diplomacy: Congress
  • How India’s Migrant Labour Struggles During Times Of Crisis
  • Farms Turn Femme But Women Still Plough Through Power Centres
  • PM Must Tell All-Party Meeting What He Told US President Trump: Congress
  • Iran-Israel ‘Threshold War’ Has Rewritten Rules Of Nuclear Escalation
  • Children’s Literature Joins The Conversation On Climate Change
  • Instead Of ‘Achhe Din’, Days Of Debt Arrived: Cong’s Dig At Modi Govt
  • A Song Of Rock And Ice
  • Access & Benefit Sharing Regulations Impinge On Rights Of Local Communities
  • Making Cuts In Implementation Of MGNREGA A Crime Against Constitution

Search

Main Links

  • Home
  • Newswires
  • Politics & Society
  • The New Feudals
  • World View
  • Arts And Aesthetics
  • For The Record
  • About Us

Related Stroy

  • Featured

Iran May Now Turn To Asymmetrical Warfare – Raising Risk Of Proxy Attacks

3 hours ago Pratirodh Bureau
  • Featured

Book Review: A Fascinating Book On India’s Rivers And Their Travails

9 hours ago Shalini
  • Featured

Giving Floral Waste A Second Life

11 hours ago Pratirodh Bureau
  • Featured

US Bombs Iran’s Nuclear Sites: What Led To It, What Happens Next?

1 day ago Pratirodh Bureau
  • Featured

Negotiating Realities In Frosty India-Bangladesh Relations

1 day ago Pratirodh Bureau

Recent Posts

  • Iran May Now Turn To Asymmetrical Warfare – Raising Risk Of Proxy Attacks
  • Book Review: A Fascinating Book On India’s Rivers And Their Travails
  • Giving Floral Waste A Second Life
  • US Bombs Iran’s Nuclear Sites: What Led To It, What Happens Next?
  • Negotiating Realities In Frosty India-Bangladesh Relations
Copyright © All rights reserved. | CoverNews by AF themes.